OpenLB
Open Library of Bioscience
Advanced Search
Blood advances
06 13, 2023;7 (11): 2431-2435.

Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells.

Katie Maurer, Haesook T Kim, Heather M Garrity, Deborah Liney, Corey Cutler, Joseph H Antin, John Koreth, Jerome Ritz, Roman M Shapiro, Rizwan Romee, Vincent T Ho, Mahasweta Gooptu, Robert J Soiffer, Catherine J Wu, Sarah Nikiforow
Author Information
  1. Katie Maurer: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. ORCID
  2. Haesook T Kim: Department of Data Science, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA.
  3. Heather M Garrity: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  4. Deborah Liney: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  5. Corey Cutler: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  6. Joseph H Antin: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  7. John Koreth: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  8. Jerome Ritz: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. ORCID
  9. Roman M Shapiro: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  10. Rizwan Romee: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  11. Vincent T Ho: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  12. Mahasweta Gooptu: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  13. Robert J Soiffer: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  14. Catherine J Wu: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. ORCID
  15. Sarah Nikiforow: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
PMID: 36595453 DOI: 10.1182/bloodadvances.2022009231

Abstract

No abstract text available.

References

  1. Transplant Cell Ther. 2021 Nov;27(11):940-948 [PMID: 34329754]
  2. Biol Blood Marrow Transplant. 2020 Jul;26(7):1312-1317 [PMID: 32283185]
  3. Biol Blood Marrow Transplant. 2007 Oct;13(10):1233-43 [PMID: 17889361]
  4. Lancet Haematol. 2019 Mar;6(3):e132-e143 [PMID: 30824040]
  5. JCI Insight. 2016;1(5): [PMID: 27213183]
  6. Am J Hematol. 2021 Feb 1;96(2):179-187 [PMID: 33108034]
  7. Biol Blood Marrow Transplant. 2008 Jun;14(6):641-50 [PMID: 18489989]
  8. Bone Marrow Transplant. 2013 Feb;48(2):243-8 [PMID: 22732701]
  9. Biol Blood Marrow Transplant. 2014 Oct;20(10):1516-21 [PMID: 24907627]
  10. Blood Adv. 2021 Feb 9;5(3):861-871 [PMID: 33560397]
  11. Am J Hematol. 2014 Jun;89(6):591-7 [PMID: 24549932]
  12. Am J Hematol. 2021 Feb 1;96(2):169-171 [PMID: 33206414]
  13. Blood Adv. 2021 Dec 14;5(23):5140-5149 [PMID: 34581754]
  14. J Clin Oncol. 2022 Feb 1;40(4):356-368 [PMID: 34855460]
  15. J Clin Invest. 2019 Mar 26;129(6):2357-2373 [PMID: 30913039]
  16. Bone Marrow Transplant. 2006 Sep;38(6):399-405 [PMID: 16892075]

Grants

  1. P01 CA229092/NCI NIH HHS
  2. P01 HL158505/NHLBI NIH HHS
  3. R01 CA279391/NCI NIH HHS
  4. R01 HL157174/NHLBI NIH HHS

MeSH Term

Humans
Incidence
Bone Marrow Transplantation
Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Article has an altmetric score of 7

Word Cloud

Created with Highcharts 10.0.0LowerincidencechronicGVHDobservedtransplantationcryopreservedunrelatedallogeneicstemcells

Similar Articles

Cited By